Clinical trial
To Investigate Prognostic Factors for Visual Improvement in Patients Undergoing Intravitreal Ranibizumab for Retinal Vein Occlusion
NCT02144662 is registered in ClinicalTrials.gov with St. Marianna University School of Medicine as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- To Investigate Prognostic Factors for Visual Improvement in Patients Undergoing Intravitreal Ranibizumab for Retinal Vein Occlusion
- Lead sponsor
- St. Marianna University School of Medicine
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- March 31, 2014
- Completion date
- April 30, 2017
- Enrollment
- 50 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
researcher-subject relations